Zhonghong Pulin Medical Products Co., Ltd. (SHE:300981)
China
· Delayed Price · Currency is CNY 12.90
-0.01 (-0.08%)
May 30, 2025, 3:04 PM CST
SHE:300981 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -85.83 | -130.87 | 66.92 | 2,342 | 2,664 | Upgrade
|
| Depreciation & Amortization | 219.54 | 205.77 | 147.87 | 80.25 | 59.66 | Upgrade
|
| Other Amortization | 2.97 | 1.48 | 0.27 | 0.01 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.85 | -0.87 | -0.43 | -3.18 | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 180.83 | 99.92 | 12.12 | 18.38 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.02 | -94.09 | -69.56 | -82.54 | -4.85 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | -1.17 | 1.87 | Upgrade
|
| Other Operating Activities | -9.85 | 143.28 | 109.63 | 148.77 | 83.49 | Upgrade
|
| Change in Accounts Receivable | -74.59 | 32.88 | 61.69 | 572.85 | -647.05 | Upgrade
|
| Change in Inventory | -124.82 | -97.43 | -44.81 | -282.03 | -164.39 | Upgrade
|
| Change in Accounts Payable | 88.22 | -112.04 | -88.86 | -421.64 | 723.99 | Upgrade
|
| Change in Other Net Operating Assets | - | 8.09 | -54.52 | - | - | Upgrade
|
| Operating Cash Flow | 183.91 | 41.71 | 106.71 | 2,362 | 2,720 | Upgrade
|
| Operating Cash Flow Growth | 340.94% | -60.91% | -95.48% | -13.13% | 1375.02% | Upgrade
|
| Capital Expenditures | -107.4 | -103.17 | -207.65 | -978.56 | -429.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.62 | 14.35 | 0.28 | 4.06 | 0.04 | Upgrade
|
| Cash Acquisitions | - | -580.56 | -35.09 | - | - | Upgrade
|
| Divestitures | - | - | - | - | 5.77 | Upgrade
|
| Investment in Securities | -485.15 | 773.93 | 102.91 | -3,186 | -378.52 | Upgrade
|
| Other Investing Activities | 78.05 | 100.97 | 64.33 | 41.62 | - | Upgrade
|
| Investing Cash Flow | -513.88 | 205.52 | -75.21 | -4,119 | -802.14 | Upgrade
|
| Long-Term Debt Issued | 976.97 | 507.8 | 225.25 | - | 198.09 | Upgrade
|
| Long-Term Debt Repaid | -603.75 | -195.01 | -153.58 | -108.26 | -420.46 | Upgrade
|
| Net Debt Issued (Repaid) | 373.21 | 312.79 | 71.67 | -108.26 | -222.37 | Upgrade
|
| Issuance of Common Stock | - | 30.8 | - | 1,918 | - | Upgrade
|
| Repurchase of Common Stock | - | -8.96 | - | - | - | Upgrade
|
| Common Dividends Paid | -215.94 | -294.64 | -501.28 | -252.07 | -587.47 | Upgrade
|
| Other Financing Activities | -18.29 | - | - | -24.63 | -0.6 | Upgrade
|
| Financing Cash Flow | 138.98 | 39.99 | -429.61 | 1,533 | -810.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 17.18 | 12.5 | 19.31 | -9.98 | -72.99 | Upgrade
|
| Net Cash Flow | -173.8 | 299.71 | -378.81 | -233.84 | 1,034 | Upgrade
|
| Free Cash Flow | 76.51 | -61.46 | -100.95 | 1,384 | 2,290 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -39.57% | 6656.11% | Upgrade
|
| Free Cash Flow Margin | 3.11% | -2.92% | -6.42% | 28.19% | 47.93% | Upgrade
|
| Free Cash Flow Per Share | 0.19 | -0.16 | -0.26 | 3.87 | 7.83 | Upgrade
|
| Cash Income Tax Paid | -104.23 | -120.18 | -99.79 | 504.59 | 374.35 | Upgrade
|
| Levered Free Cash Flow | - | -264.65 | -124.14 | 428.97 | 1,880 | Upgrade
|
| Unlevered Free Cash Flow | - | -255.05 | -123.1 | 429.98 | 1,886 | Upgrade
|
| Change in Net Working Capital | - | 250.27 | -27.46 | 355.02 | -214.24 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.